Abstract
Microvascular injury is associated with accelerated kidney transplant dysfunction and allograft failure. Molecular pathology can identify new mechanisms of microvascular injury while improving on the diagnostic and prognostic capabilities of traditional histology. We conducted a case-control study of archived kidney biopsy specimens stored up to 10 years with microvascular injury (n = 50) compared with biopsy specimens without histologic injury (n = 45) from patients of similar age, race, and sex. We measured WNT gene expression with a multiplex quantification platform by using digital barcoding, given the importance of WNT reactivation to the response to wounding in the kidney microvasculature and other compartments. Of 210 genes from a commercial WNT panel, 71 were associated with microvascular injury and 79 were associated with allograft failure, with considerable overlap of genes between each set. Molecular pathology identified 46 biopsy specimens with molecular evidence of microvascular injury; 18 (39%) were either C4d negative, donor-specific antibody negative, or had no microvascular injury by histology. The majority of cases with molecular evidence of microvascular injury had poor long-term outcomes. We identified novel WNT pathway genes associated with microvascular injury and allograft failure in residual clinical biopsy specimens obtained up to 10 years earlier. Further mechanistic studies may identify the WNT pathway as a new diagnostic and therapeutic target.
Original language | English |
---|---|
Pages (from-to) | 2833-2845 |
Number of pages | 13 |
Journal | American Journal of Transplantation |
Volume | 19 |
Issue number | 10 |
DOIs | |
State | Published - Oct 1 2019 |
Bibliographical note
Funding Information:Funding information This work was supported by grants K23 DK101690 and L40 DK099748 from the National Institute of Diabetes and Digestive and Kidney Diseases (to Dr Seifert). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors wish to thank Keith Hruska for his WNT pathway expertise and initial scientific discussions that helped shape this project and Jennifer Pollock for ongoing scientific discussion and advice throughout the project. The authors also wish to thank Diane Solomon for her assistance in procuring biospecimens from the Washington University Kidney Translational Research Center for this study.
Publisher Copyright:
© 2019 The American Society of Transplantation and the American Society of Transplant Surgeons
Keywords
- antibody-mediated rejection (ABMR)
- genomics
- graft survival
- kidney (allograft) function/dysfunction
- kidney transplantation/nephrology
- pathology/histopathology
- rejection
- translational research/science
- vascular biology
ASJC Scopus subject areas
- Immunology and Allergy
- Transplantation
- Pharmacology (medical)